-
GlaxoSmithKline signed an agreement and obtained the exclusive license of hepatitis B drug JNJ-3989
On October 31st local time, GlaxoSmithKline and Arrowhead Pharmaceuticals announced that they had reached an agreement with Janssen Pharmaceuticals, a subsidiary of Johnson&Johnson, to transfer the g ... -
Accelerating the Internationalization Strategy to Promote the Cooperation between Hengrui Pharmaceuticals and German Merck
On October 30th, Jiangsu Hengrui Pharmaceutical Co., Ltd. (hereinafter referred to as "Hengrui Pharmaceutical", 600276. SH) announced that it had reached an agreement with German Merck. Hengrui Pharm ... -
Baiji Shenzhou Small Molecular Innovative Drug Global Industrialization Base Launched in Suzhou
Shanghai Securities News China Securities Network News (Reporter Zhang Xue): The reporter learned from Baekje Shenzhou that on November 16th, the Baekje Shenzhou Small Molecule Innovative Drug Global ... -
Nvidia collaborates with Genentech to accelerate drug development using generative AI
On November 21st, Nvidia announced a partnership with Genentech to accelerate drug development using generative artificial intelligence. -
Nvidia collaborates with Genentech to accelerate drug development using generative AI
On November 21st, Nvidia announced a partnership with Genentech to accelerate drug development using generative AI.